Summary: Weight loss injections including semaglutide and liraglutide should not be used during breastfeeding according to UK prescribing guidance due to lack of human safety data
The first comprises the exendin-4 derivatives (exenatide and lixisenatide), whose structure is based on the peptide sequence of exendin-4, which was isolated from the saliva of the Gila monster lizard (Nauck et al, 2021)
It also came with some lemon honey, which I wasnt totally sure what to do with until I saw it was recommended for lemonade, tea, and waffles or pancakes so I tried all three, and boy is it good
Practical help in 4 modules Module 1 Webinar Now available On Demand Understanding the issues around the GLP-1 RA shortage Understanding the impact of the current GLP-1 RA shortage Making sense of the guidance published Identifying and prioritising those affected Practical resources to support clinicians Plus downloadable guides: Module 2 Webinar Now available On Demand Tackling the GLP-1 RA shortage in clinical practice: A consultation guide Applying national guidance in practice Promoting patient-centred discussion Identifying appropriate alternatives to GLP-1 RAs Working through practical case examples Plus downloadable guides: Module 3 Common patient scenarios Now available on demand Module 4 Webinar Where are we now

CagriSema vs Retatrutide: Amylin/GLP-1 Combination vs Triple Agonist Comparison Evidence-based comparison of CagriSema (cagrilintide + semaglutide amylin/GLP-1 combination) and retatrutide (GIP/GLP-1/glucagon triple agonist) for weight loss and metabolic disease based on Phase 2-3 clinical trial data